Manuela Prenna

813 total citations
42 papers, 648 citations indexed

About

Manuela Prenna is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Manuela Prenna has authored 42 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 17 papers in Epidemiology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Manuela Prenna's work include Antimicrobial Resistance in Staphylococcus (16 papers), Streptococcal Infections and Treatments (14 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Manuela Prenna is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (16 papers), Streptococcal Infections and Treatments (14 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Manuela Prenna collaborates with scholars based in Italy, Belgium and Nigeria. Manuela Prenna's co-authors include Sandro Ripa, Luca A. Vitali, Dezemona Petrelli, Claudia Zampaloni, Luigi Ferrante, Pietro E. Varaldo, Fiorenzo Mignini, Guido Pasquantonio, Maria Pia Montanari and Adebayo Lamikanra and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Manuela Prenna

41 papers receiving 618 citations

Peers

Manuela Prenna
J. P. Maskell United Kingdom
J. Perlroth United States
I.M. Gould United Kingdom
Laura Mandel United States
J. Naidoo United Kingdom
Manuela Prenna
Citations per year, relative to Manuela Prenna Manuela Prenna (= 1×) peers Sandro Ripa

Countries citing papers authored by Manuela Prenna

Since Specialization
Citations

This map shows the geographic impact of Manuela Prenna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Prenna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Prenna more than expected).

Fields of papers citing papers by Manuela Prenna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Prenna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Prenna. The network helps show where Manuela Prenna may publish in the future.

Co-authorship network of co-authors of Manuela Prenna

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Prenna. A scholar is included among the top collaborators of Manuela Prenna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Prenna. Manuela Prenna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vitali, Luca A., et al.. (2015). Correlation between genetic features of the mef (A)- msr (D) locus and erythromycin resistance in Streptococcus pyogenes. Diagnostic Microbiology and Infectious Disease. 84(1). 57–62. 8 indexed citations
2.
Vitali, Luca A., Dezemona Petrelli, Adebayo Lamikanra, Manuela Prenna, & Ezekiel Olugbenga Akinkunmi. (2014). Diversity of antibiotic resistance genes and staphylococcal cassette chromosome mec elements in faecal isolates of coagulase-negative staphylococci from Nigeria. BMC Microbiology. 14(1). 106–106. 33 indexed citations
3.
Petrelli, Dezemona, et al.. (2013). Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy. European Journal of Clinical Microbiology & Infectious Diseases. 33(2). 241–244. 6 indexed citations
4.
Petrelli, Dezemona, Elisabetta Bolli, Maurizio Falconi, et al.. (2011). A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates. Diagnostic Microbiology and Infectious Disease. 70(3). 387–394. 1 indexed citations
5.
Pasquantonio, Guido, Claudio Greco, Manuela Prenna, et al.. (2008). Antibacterial Activity and Anti-Biofilm Effect of Chitosan against Strains of Streptococcus Mutans Isolated in Dental Plaque. International Journal of Immunopathology and Pharmacology. 21(4). 993–997. 37 indexed citations
6.
Petrelli, Dezemona, Claudia Zampaloni, Simonetta D’Ercole, et al.. (2006). Analysis of different genetic traits and their association with biofilm formation in Staphylococcus epidermidis isolates from central venous catheter infections. European Journal of Clinical Microbiology & Infectious Diseases. 25(12). 773–781. 43 indexed citations
7.
Drago, Lorenzo, Elena De Vecchi, L. Nicola, et al.. (2005). In VitroSelection of Resistance to Clarithromycin inStreptococcus pneumoniaeClinical Isolates. Journal of Chemotherapy. 17(2). 161–168. 3 indexed citations
8.
Petrelli, Dezemona, Manuela Prenna, Claudia Zampaloni, et al.. (2005). Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy. Clinical Microbiology and Infection. 11(11). 927–930. 12 indexed citations
10.
Zampaloni, Claudia, et al.. (2002). Erythromycin Resistance in Italian Isolates of Streptococcus pyogenes and Correlations with Pulsed-Field Gel Electrophoresis Analysis. Microbial Drug Resistance. 8(1). 39–44. 13 indexed citations
11.
Ripa, Sandro, Claudia Zampaloni, Luca A. Vitali, et al.. (2001). Sma I Macrorestriction Analysis of Italian Isolates of Erythromycin-Resistant Streptococcus pyogenes and Correlations with Macrolide-Resistance Phenotypes. Microbial Drug Resistance. 7(1). 65–71. 39 indexed citations
12.
Montanari, Maria Pia, Manuela Prenna, Marina Mingoia, Sandro Ripa, & Pietro E. Varaldo. (1998). In vitro Antibacterial Activity of Trovafloxacin and Five Other Fluoroquinolones. Chemotherapy. 44(2). 85–93. 14 indexed citations
13.
Prenna, Manuela, Maria Pia Montanari, Marina Mingoia, et al.. (1998). Antistaphylococcal and Antistreptococcal Killing Kinetics of Ciprofloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin. European Journal of Clinical Microbiology & Infectious Diseases. 17(11). 816–819. 4 indexed citations
14.
Facinelli, Bruna, Gloria Magi, Manuela Prenna, Sandro Ripa, & Pietro E. Varaldo. (1997). In vitro extracellular and intracellular activity of two newer and two earlier fluoroquinolones againstListeria monocytogenes. European Journal of Clinical Microbiology & Infectious Diseases. 16(11). 827–833. 15 indexed citations
15.
Giovanetti, Eleonora, Manuela Prenna, Francesca Biavasco, et al.. (1997). Susceptibility of Streptococcus pyogenes from throat cultures to macrolide antibiotics and influence of collection criteria. Clinical Microbiology and Infection. 3(1). 58–62. 6 indexed citations
16.
Ripa, Sandro, Luigi Ferrante, & Manuela Prenna. (1996). A Linear Model for the Pharmacokinetics of Azithromycin in Healthy Volunteers. Chemotherapy. 42(6). 402–409. 14 indexed citations
17.
Ripa, Sandro, Luigi Ferrante, & Manuela Prenna. (1993). Pharmacokinetics of Fluconazole in Normal Volunteers. Chemotherapy. 39(1). 6–12. 45 indexed citations
18.
Ripa, Sandro, Luigi Ferrante, & Manuela Prenna. (1990). Pharmacokinetics of Sulbactam/Ampicillin in Humans after Intravenous and Intramuscular Injection. Chemotherapy. 36(3). 185–192. 16 indexed citations
19.
Ripa, Sandro, et al.. (1987). In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp.. PubMed. 13(8). 483–8. 33 indexed citations
20.
Pannelli, F, Sandro Ripa, Fiorenzo Mignini, & Manuela Prenna. (1985). [Production of coagulase and thermonuclease in 366 strains of staphylococci belonging to different lyogroups].. PubMed. 64(2). 115–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026